China NMPA Inspection - Gansu Boxiang Pharmaceutical Co., Ltd. - January 25, 2019
China NMPA unannounced inspection for Gansu Boxiang Pharmaceutical Co., Ltd. published January 25, 2019. Gansu Boxiang Pharmaceutical Co., Ltd. underwent an unannounced inspection by the National Medical Products Administration Audit and Inspection Center
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA unannounced inspection for Gansu Boxiang Pharmaceutical Co., Ltd. published January 25, 2019. Gansu Boxiang Pharmaceutical Co., Ltd. underwent an unannounced inspection by the National Medical Products Administration Audit and Inspection Center
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
Unknown Date
Product Type
Drugs
ID: ca3ad57c-e11a-400f-8d44-4254bee3d33e
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox